Efficacy and safety of radiotherapy in acromegaly

Archives of Medical Research

Volumn 42, Issue 1, 2011, Pages 48-52

  González, Baldomero ^a   Vargas, Guadalupe ^a   Espinosa de los Monteros, Ana Laura ^a   Sosa, Ernesto ^a   Mercado, Moisés ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Acromegaly; GH; Hypopituitarism; IGF 1; Radiotherapy

Indexed keywords

ESTRADIOL; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; PROLACTIN; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; THYROXINE;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ACROMEGALY; ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COST CONTROL; DISEASE ACTIVITY; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPOCORTISOLISM; HYPOGONADISM; HYPOPITUITARISM; HYPOTHYROIDISM; MALE; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PATIENT SAFETY; RADIATION DOSE; TRANSSPHENOIDAL SURGERY; TREATMENT FAILURE; TREATMENT OUTCOME;

ACROMEGALY; ADULT; AGED; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY HORMONES; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 79952082109     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.01.004     Document Type: Article

References (18)

1. Ben-Shlomo A., Melmed S. Acromegaly. Endocrinol Metab Clin North Am 2008, 37:101-122.
2. Arellano S., Aguilar P., Domínguez B., et al. Segundo Consenso Nacional de Acromegalia: Recomendaciones para su diagnóstico, tratamiento y seguimiento. Rev Endocrinol Nutr 2007, 15:7-16.
3. Melmed S. Acromegaly. N Engl J Med 2006, 355:2558-2673.
4. Attanasio R., Epaminonda P., Motti E., et al. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 2003, 88:3105-3112.
5. Colao A., Ferone D., Marzullo P., et al. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004, 25:102-152.
6. Trepp R., Stettler C., Zwahlen M., et al. Treatment outcomes and mortality of 94 patients with acromegaly. Acta Neurochir 2005, 147:243-251.
7. Lee Vance M., Laws E. Role of medical therapy in the management of acromegaly. Neurosurgery 2005, 56:877-885.
8. Freda P., Katznelson L., Jan Van der Lely A., et al. Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. J Clin Endocrinol Metab 2005, 90:4465-4473.
9. Trainer P.J., Drake W.M., Katznelson L., et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 2000, 342:1171-1177.
10. Muller A., Kopchick J., Flyvbjerg A., et al. Growth hormone receptor antagonists. J Clin Endocrinol Metab 2004, 89:1503-1511.
11. Lindberg-Larsen R., Moller N., Schmitz O., et al. The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly. J Clin Endocrinol Metab 2007, 92:1724-1728.
12. Brada M., Jankowska P. Radiotherapy for pituitary adenomas. Endocrinol Metab Clin North Am 2008, 37:263-275.
13. Biermasz N., Dulken H., Roelfsema F. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 2000, 85:2476-2482.
14. Barrande G., Pittino-Lungo M., Coste J., et al. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 2000, 85:3779-3785.
15. Ayuk J., Clayton R.N., Holder G., et al. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 2004, 89:1613-1617.
16. Jenkins P.J., Bates P., Carson M.N., et al. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 2006, 91:1239-1245.
17. ® (Long-Acting Repeatable Octreotide) in the primary therapy of patients with acromegaly. Clin Endocrinol 2007, 66:859-868.
18. Kauppinen-Mäkelin R., Sane T., Reunanen A., et al. A Nation-wide survey of mortality in acromegaly. J Clin Endocrinol Metab 2005, 90:4081-4086.